Literature DB >> 9240840

Lesions of experimental equine morbillivirus pneumonia in horses.

P T Hooper1, P J Ketterer, A D Hyatt, G M Russell.   

Abstract

Laboratory examinations of equine morbillivirus included experimental reproductions of the disease caused by the virus by transmission of mixed lung and spleen taken from two field equine cases into two horses and by inoculating tissue culture virus into a further two horses. The most distinctive gross lesions of the diseases that developed in three of the horses was that of pulmonary edema characterized by gelatinous distension of subpleural lymphatics. Histologically, the lesions in the lungs were those of serofibrinous alveolar edema, alveolar macrophages, hemorrhage, thrombosis of capillaries, and syncytial cells. Clearly defined vascular lesions in three horses that became clinically affected within 8 days of inoculation of virus included intramural hemorrhage, edema, and necrosis and syncytial cells in the endothelium of pulmonary vessels (approximately 40-70 microm in diameter). Vascular lesions accompanied by parenchymal degeneration were also seen in the heart, kidney, brain, spleen, lymph node, and stomach. A fourth horse, which survived for 12 days, had detectable lesions only in the lungs, which were more chronic than those in the other three horses, a greater degree of cellular infiltration, and fewer well-defined vascular lesions. Sections stained by an indirect immunocytochemical method showed equine morbillivirus antigen was present in the vascular lesions and along alveolar walls. When endothelial cells were examined by electron microscope, cytoplasmic virus inclusion bodies containing filamentous structures were seen that reacted to an immunogold test to equine morbillivirus antigen. The presence of the syncytia in the small blood vessels in the lungs and other organs was interpreted as an important characteristic of the disease and consistent with a reaction to a morbillivirus.

Entities:  

Mesh:

Year:  1997        PMID: 9240840     DOI: 10.1177/030098589703400407

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  19 in total

1.  New virus emerges in Malaysia.

Authors:  C E Caplan
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

Review 3.  Transmission of henipaviruses.

Authors:  Sarah Weatherman; Heinz Feldmann; Emmie de Wit
Journal:  Curr Opin Virol       Date:  2017-10-14       Impact factor: 7.090

4.  Characterization of equine E-selectin.

Authors:  J F Hedges; C D Demaula; B D Moore; B E McLaughlin; S I Simon; N J MacLachlan
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

Review 5.  Emerging tropical diseases in Australia. Part 5. Hendra virus.

Authors:  S M Tulsiani; G C Graham; P R Moore; C C Jansen; A F Van Den Hurk; F A J Moore; R J Simmons; S B Craig
Journal:  Ann Trop Med Parasitol       Date:  2011-01

Review 6.  Immunization strategies against henipaviruses.

Authors:  Christopher C Broder; Thomas W Geisbert; Kai Xu; Dimitar B Nikolov; Lin-Fa Wang; Deborah Middleton; Jackie Pallister; Katharine N Bossart
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 7.  Henipavirus receptor usage and tropism.

Authors:  Olivier Pernet; Yao E Wang; Benhur Lee
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 8.  Hendra virus.

Authors:  Deborah Middleton
Journal:  Vet Clin North Am Equine Pract       Date:  2014-09-30       Impact factor: 1.792

9.  Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands.

Authors:  Glenn A Marsh; Jessica Haining; Timothy J Hancock; Rachel Robinson; Adam J Foord; Jennifer A Barr; Shane Riddell; Hans G Heine; John R White; Gary Crameri; Hume E Field; Lin-Fa Wang; Deborah Middleton
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.